Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

NCT01312493 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding source was terminated before enrollment of first subject

Conditions

Head and Neck Cancer

Interventions

DRUG: Panitumumab
RADIATION: Intensity Modulated Radiation Therapy

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]